Avant-garde of RNA Therapeutics
We develop novel RNA-based therapeutics that will be able to bring about a paradigm shift for neurodegenerative diseases.
Our Journey for RNA therapeutics
From novel target discovery to first-in-class drug development, we are dedicated to becoming the pioneers of RNA therapeutics
Our Science We develop RNA-based therapeutics for neuroinflammatory diseases, with a particular focus on comprehensive patient care. We have complementary discovery platforms that cover all the way from diagnosis to treatment monitoring
The programs in our R&D pipeline are focusing on RNA-based therapeutics that treat neurodegenerative diseases. Each program addresses a target that is validated to cause or increase the risk for neurodegenerative diseases in genetics, cell biology, and bioinformatics
click the symbol to switch slides